“…Endobronchial coil migration as a long-term complication is rare, with only 13 reported cases (Table 2) (1,(9)(10)(11)(12)(13)(14)(15)(16)(17)(18). In 7 of the 13 patients, coil migration occurred more than a year after coil embolization, with a median period of 2.3 (1.2-12) years.…”
An 87-year-old woman who had undergone coil embolization 25 years ago for pulmonary arteriovenous fistula, which was diagnosed following repeated cerebral infarction, presented with massive hemoptysis. The coils migrated and were excreted in stool following hemoptysis during long-term follow-up. Although the technical success rate of coil embolization for pulmonary arteriovenous malformations is extremely high, and coil embolization-related complications are rare, little is known about the long-term complications. We herein report the clinical course of our case, review previous reports related to coil migration as a long-term complication, and discuss the associated mechanism.
“…Endobronchial coil migration as a long-term complication is rare, with only 13 reported cases (Table 2) (1,(9)(10)(11)(12)(13)(14)(15)(16)(17)(18). In 7 of the 13 patients, coil migration occurred more than a year after coil embolization, with a median period of 2.3 (1.2-12) years.…”
An 87-year-old woman who had undergone coil embolization 25 years ago for pulmonary arteriovenous fistula, which was diagnosed following repeated cerebral infarction, presented with massive hemoptysis. The coils migrated and were excreted in stool following hemoptysis during long-term follow-up. Although the technical success rate of coil embolization for pulmonary arteriovenous malformations is extremely high, and coil embolization-related complications are rare, little is known about the long-term complications. We herein report the clinical course of our case, review previous reports related to coil migration as a long-term complication, and discuss the associated mechanism.
“…Endovascular coil embolization is an accepted method for the treatment of pseudoaneurysms with excellent success rates. 1 Coil migration is a well-documented postembolization complication in endovascular procedures, with varying rates of occurrence (neurovascular procedures: 2-6%; few cases have been reported with bronchial artery embolization, 2 and less than five cases have been published with pulmonary artery embolization of pseudoaneurysms [3][4][5][6] ). Depending on the structure the coil migrates into, it can have differing outcomes ranging from tissue hypoperfusion (parenchymal ischemia) from occlusion of nontarget vessels to massive hemorrhage and potential fatality from rupture or instrumentation trauma to the pseudoaneurysm.…”
The authors report a case of endobronchial migration of a POD packing coil following embolization of a pulmonary artery pseudoaneurysm in a patient with cavitary tuberculosis and its successful management by bronchoscopy-assisted removal of the coil. Coil migration may be secondary to continued cough and persistence of a bronchial to pulmonary artery fistula from tuberculous infection and inflammation.
“…Although few cases of coil migration from pulmonary AVMs have been reported [ 13 , 14 ], coil migration after embolotherapy for other lung pathologies have also been documented. Cases include intrabronchial migration after coil embolization of pulmonary arterial aneurysms [17] and pseudoaneurysms [18] as well as from bronchial artery embolization [19] . Coil migration from pulmonary embolization can also cause more serious complications, such as fistulization [20] , migration to the heart [ 11 , 21 , 22 ], pulmonary hypertension [11] , pneumothorax [23] , erosion into the bronchus [15] , and migration into the contralateral pulmonary vasculature [22] .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.